Small intestinal stromal tumors: A clinicopathologic study of 31 tumors

Pathology International

Volumn 48, Issue 5, 1998, Pages 341-347

  Chang, Mee Soo ^a   Choe, Gheeyoung ^a   Kim, Woo Ho ^a   Kim, Yong Il ^a,b  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Ki 67; p53; Prognosis; Small intestine; Stromal tumor

Indexed keywords

ALPHA ACTIN; CD34 ANTIGEN; DESMIN; KI 67 ANTIGEN; PROTEIN P53; PROTEIN S 100; VIMENTIN;

ADULT; AGED; ARTICLE; BENIGN TUMOR; CANCER MORTALITY; CELL DEATH; CONTROLLED STUDY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MALIGNANT NEOPLASTIC DISEASE; MELENA; METASTASIS; MITOSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SMALL INTESTINE TUMOR; STROMA; TUMOR RECURRENCE; TUMOR VOLUME;

EID: 7344219816     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1827.1998.tb03916.x     Document Type: Article

References (25)

1. Ranchord M, Kempson RL. Smooth muscle tumors of the gastrointestinal tract and retroperitoneum: A pathologic analysis of 100 cases. Cancer 1977; 39: 255-262.
2. Akwari OE, Dozois RR, Weiland LH, Beahers OH. Leiomyosarcoma of the small and large bowel. Cancer 1978; 42: 1375-1384.
3. Brainard JA, Goldblum JR. Stromal tumors of the jejunum and ileum: A clinicopathologic study of the 39 cases. Am. J. Surg. Pathol. 1997; 21: 407-416.
4. Franquemont DW, Frierson HF. Muscle differentiation and clinicopathologic features of gastrointestinal stromal tumors. Am. J. Surg. Pathol. 1992; 16: 947-954.
5. Goldblum JR, Appelman HD. Stromal tumors of the duodenum: A histologic and immunohistochemical study of 20 cases. Am. J. Surg. Pathol. 1995; 19: 71-80.
6. Hollstein M, Sindransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 1991; 350: 427-428.
7. Levine AJ, Momand J, Finlay CA. The p53 tumor suppressor gene. Nature 1991; 351: 453-456.
8. Cai JH, Jiang YK, Zhang YY. Flow cytometric quantitation of p53 protein expression in gastrointestinal smooth muscle tumors: Clinicopathological correlation and prognostic significance. Chung Hua Wai Ko Tsa Chih 1994; 32: 483-486.
9. Yu CC, Fletcher CD, Newman PL, Goodlad JR, Burton JC, Levison DA. A comparison of proliferating cell nuclear antigen (PCNA) immunostaining, nucleolar organizer region (AgNOR) staining, and histological grading in gastrointestinal stromal tumors. J. Pathol. 1992; 166: 147-152.
10. Amin MB, Ma CK, Linden MD, Kubus JJ, Zarbo RJ. Prognostic value of proliferating cell nuclear antigen index in gastric stromal tumors: Correlation with mitotic count and clinical outcome. Am. J. Clin. Pathol. 1993; 100: 428-432.
11. Ray R, Tahan SR, Andrews C, Goldman H. Stromal tumors of the stomach: Prognostic value of the PCNA index. Mod. Pathol. 1994; 17: 26-30.
12. Sbaschnig RJ, Cunningham RE, Sobin LH, Oleary TJ. Proliferating-cell nuclear antigen immunocytochemistry in the evaluation of gastrointestinal smooth-muscle tumors. Mod. Pathol. 1994; 7: 780-783.
13. Franquemont DW, Frierson HF. Proliferating cell nuclear antigen immunoreactivity and prognosis of gastrointestinal stromal tumors. Mod. Pathol. 1995; 8: 473-477.
14. Lam KY, Law SY-K, So MK-P, Fok M, Ma LT, Wong J. Prognostic implication of proliferative markers MIB-1 and PC10 in esophageal squamous cell carcinoma. Cancer 1996; 77: 7-13.
15. Rose DSC, Maddox PH, Brown DC. Which proliferation marker for routine immunohistology? A comparison of five antibodies. J. Clin. Pathol. 1994; 47: 1010-1014.
16. Cattoretti G, Becker MH, Key G et al. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB1 and MIB3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J. Pathol. 1992; 168: 357-363.
17. Yuki M, Yokota K, Okuyama S. Cell proliferation and cell death (apoptosis) as indices differentiating malignant from benign gastrointestinal myogenic tumors. Nippon Shokakibyo Gakkai Zasshi 1995; 92: 206-216.
18. Kawamura T, Goseki N, Koike M, Takizawa T, Endo M. Acceleration of proliferative activity of esophageal squamous cell carcinoma with invasion beyond mucosa: Immunohistochemical analysis of Ki-67 and p53 antigen in relation to histopathologic findings. Cancer 1996; 77: 843-849.
19. Sporgoe JS, Holund B. Immunohistochemistry (Ki-67 and p53) as a tool in determining malignancy in smooth muscle neoplasm (exemplified by a myxoid leiomyosarcoma of the uterus). APMIS 1996; 104: 705-708.
20. Carrillo R, Candia A, Rodriguez-Peralto JL, Caz V. Prognostic significance of DNA ploidy and proliferative index (MIB-1 index) in gastrointestinal stromal tumors. Hum. Pathol. 1997; 28: 160-165.
21. Appelman HD. Smooth muscle tumors of the gastrointestinal tract: What we know now that Stout didn't know. Am. J. Pathol. 1986; 10 (Suppl.1): 83-99.
22. Slootweg PJ, Koole R, Hordijk GJ. The presence of p53 protein in relation to Ki-67 as cellular proliferation marker in head and neck squamous cell carcinoma and adjacent dysplastic mucosa. Eur. J. Cancer B Oral Oncol. 1994; 30B : 138-141.
23. Morkve O, Halvorsen OJ, Stangeland L, Gulsvik A, Laerum OD. Quantitation of biological tumor markers (p53, c-myc, Ki-67 and DNA ploidy) by multiparameter flow cytometry in non-small cell lung cancer. Int. J. Cancer 1992; 52: 851-855.
24. Evans HL. Smooth muscle tumors of the gastrointestinal tract: A study of 56 cases followed for a minimum of 10 years. Cancer 1985; 56: 2242-2250.
25. Min K-W. Small intestinal stromal tumors with skeinoid fibers: Clinicopathological, immunohistochemical, and ultrastructural investigations. Am. J. Surg. Pathol. 1992; 16: 145-155.